5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 53.67▲ | 53.30▲ | 53.18▲ | 52.93▲ | 66.05▼ |
MA10 | 53.60▲ | 53.03▲ | 52.71▲ | 60.24▼ | 69.76▼ |
MA20 | 53.38▲ | 52.56▲ | 52.74▲ | 67.47▼ | 67.24▼ |
MA50 | 53.10▲ | 52.54▲ | 54.02▼ | 71.04▼ | 71.43▼ |
MA100 | 52.68▲ | 55.58▼ | 64.73▼ | 67.56▼ | 77.84▼ |
MA200 | 52.65▲ | 65.46▼ | 69.90▼ | 71.07▼ | 75.15▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.022▲ | 0.153▲ | 0.425▲ | -2.201▼ | -1.129▼ |
RSI | 69.228▲ | 65.041▲ | 52.585▲ | 25.340▼ | 33.573▼ |
STOCH | 89.181▲ | 85.829▲ | 81.503▲ | 6.677▼ | 43.115 |
WILL %R | -24.818▲ | -8.808▲ | -7.173▲ | -88.294▼ | -89.538▼ |
CCI | 110.529▲ | 192.265▲ | 146.049▲ | -73.111 | -252.211▼ |
Tuesday, August 12, 2025 01:23 PM
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the ...
|
Tuesday, August 12, 2025 01:21 PM
Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of ...
|
Tuesday, August 12, 2025 05:23 AM
Q1 2026 Earnings Call Transcript August 9, 2025 Operator: Good day, and thank you for standing by. Welcome to the Haemonetics Corporation First Quarter 2026 Earnings Call. [Operator Instructions].
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 52.56 | 53.88 | 51.99 | 53.74 | 1,238,300 |
14/08/25 | 53.03 | 53.78 | 51.47 | 52.33 | 1,398,200 |
13/08/25 | 52.25 | 54.06 | 51.83 | 53.88 | 1,274,600 |
12/08/25 | 53.03 | 53.33 | 50.68 | 52.23 | 1,546,400 |
11/08/25 | 53.80 | 54.78 | 52.29 | 52.47 | 1,335,900 |
08/08/25 | 55.25 | 55.69 | 53.25 | 53.99 | 2,688,500 |
07/08/25 | 72.08 | 72.15 | 55.32 | 55.63 | 5,367,700 |
06/08/25 | 76.34 | 76.62 | 75.13 | 75.77 | 869,300 |
05/08/25 | 76.07 | 76.82 | 75.615 | 76.11 | 1,025,660 |
04/08/25 | 74.74 | 76.36 | 74.70 | 76.30 | 451,100 |
|
|
||||
|
|
||||
|
|